Royal Biologics Launches Advanced-Cell Bone Grafting Kit Orthobiologics ORTHOFLASH Advanced-Cell combines multiple autologous and advanced bone grafting technologies all in one convenience kit. Apr 27, 2022
Empirical Spine Submits PMA Module II for Limiflex ORTHOFLASH Spine LimiFlex is designed to restore natural segmental motion and stability after lumbar decompression by augmenting the posterior tension band. Apr 27, 2022
Sonex Launches UltraGuideTFR to Treat Trigger Finger ORTHOFLASH Sports Medicine UltraGuideTFR is indicated for the treatment of trigger finger and is designed to incise the tendon sheath and A1 pulley through a single incision. Apr 27, 2022
Medline UNITE launches New Foot/Ankle Implants ORTHOFLASH Trauma The company launched the FDA-cleared Calcaneal Fracture Plating System and Intramedullary Nail Fibula Implant. Apr 26, 2022
First U.S. Lumbar Fusion with Medacta Augmented Reality ORTHOFLASH Robotics/Tech The combined the M.U.S.T. Pedicle Screw with NextAR Spine, an FDA-cleared AR-based surgical application for intra-op guidance in spine. Apr 26, 2022
CTL Amedica Gains U.S. Patent for KLIMT Expandable Lumbar Cage ORTHOFLASH Spine CTL Amedica's KLIMT Expandable Lumbar Interbody Fusion Cage design features proprietary, 3D-printed expandable technology. Apr 26, 2022
ORHub Acquires PUR Biologics Competitive Landscape Mergers & Acquisitions ORHub will enter the medical device market with biologics to regenerate cartilage and address degenerative disc disease and osteoarthritis. Apr 25, 2022
CoNextions TR Tendon Repair Receives FDA Clearance ORTHOFLASH Sports Medicine CoNextions was granted FDA 510(k) clearance to market the CoNextions TR® Tendon Repair System. Expected to launch in May 2022,... Apr 25, 2022
Study Results: Bioretec ActivaPin in Pediatric Fracture ORTHOFLASH Trauma Bioretec's ActivaPin bioresorbable implant demonstrated excellent clinical outcomes in the treatment of pediatric wrist fractures. Apr 25, 2022
OssDsign Completes Enrollment in Spinal Fusion Study Orthobiologics ORTHOFLASH The 2-year study will assess the use of OssDsign Catalyst synthetic bone graft in spinal fusion surgery. Apr 25, 2022